Cart
sales@molnova.com
CPDA
CAS No. 1415834-63-7
CPDA( —— )
Catalog No. M26128 CAS No. 1415834-63-7
CPDA is a new potent inhibitor of SH2 domain-containing inositol phosphatase 2 (SHIP2).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 43 | In Stock |
|
| 5MG | 39 | In Stock |
|
| 10MG | 65 | In Stock |
|
| 25MG | 128 | In Stock |
|
| 50MG | 211 | In Stock |
|
| 100MG | 333 | In Stock |
|
| 200MG | 458 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCPDA
-
NoteResearch use only, not for human use.
-
Brief DescriptionCPDA is a new potent inhibitor of SH2 domain-containing inositol phosphatase 2 (SHIP2).
-
DescriptionCPDA is a new potent inhibitor of SH2 domain-containing inositol phosphatase 2 (SHIP2).(In Vitro):CPDA enhances insulin signaling.(In Vivo):CPDA greatly improves abnormal glucose metabolism in diabetic animals. In db/db mice, CPDA improves abnormal glucose metabolism.
-
In VitroCPDA enhances insulin signaling.
-
In VivoCPDA greatly improves abnormal glucose metabolism in diabetic animals. CPDA improves the abnormal glucose metabolism in db/db mice.
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPhosphatase
-
RecptorSmoothened
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1415834-63-7
-
Formula Weight388.8
-
Molecular FormulaC20H15ClF2N2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 50 mg/mL (128.60 mM)
-
SMILESFc1cccc(F)c1CC(=O)Nc1cc(OCc2ccc(Cl)cc2)ccn1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Solinas et al (2012) Acylthiourea, acylurea, and acylguanidine derivatives with potent hedgehog inhibiting activity. J.Med.Chem. 55 1559
molnova catalog
related products
-
Raphin1
Raphin1 is an orally bioavailable selective inhibitor of the regulatory phosphatase PPP1R15B (R15B).
-
h-NTPDase8-IN-1
h-NTPDase8-IN-1 is a specific aminosulfonylbenzamide inhibitor of h-NTPDases8 (IC 50 = 0.28 ± 0.07 μM). h-NTPDase8-IN-1 can be used to study diseases brought about by aberrant h -NTPDase expression.
-
RMC-4630
RMC-4630 is an inhibitor of SHP2.
